MetaVia Reports Preclinical Data on DA-1726 Waist Reduction
Cambridge, Massachusetts, September 9, 2026 MetaVia Inc., a clinical-stage biotechnology company focused on cardiometabolic diseases, has reported new preclinical...
metabolic dysfunction-associated steatohepatitis
Advertisement
Altimmune Initiates PERFORMA Phase 3 Trial of Pemvidutide for MASH
GAITHERSBURG, Md., Aug. 3, 2026 Altimmune, Inc. has initiated patient enrollment in the global PERFORMA Phase 3 registrational trial...
Madrigal Pharmaceuticals Secures Three New Resmetirom U.S. Patents
CONSHOHOCKEN, Pa., July 13, 2026 Madrigal Pharmaceuticals announced that the U.S. Patent and Trademark Office (USPTO) has issued three...
GENFIT Secures U.S. Medicare Coverage for NASHnext Diagnostic Test
Lille, France; Cambridge, Massachusetts, United States; and Zurich, Switzerland, July 2, 2026 GENFIT announced that U.S. Medicare has approved...
PDS Biotechnology Presents Strong Immunotherapy and Translational Data Demonstrating Broad Immune Activation at SITC 2025
Princeton, New Jersey, November 10, 2025 — PDS Biotechnology Corporation, a clinical-stage biopharmaceutical company developing next-generation immunotherapies for cancer...
Advertisements
Rivus Pharmaceuticals Reports Positive Phase 2 Results for HU6 in MASH Patients
CHARLOTTESVILLE, Va., and SOUTH SAN FRANCISCO, Calif., November 7, 2025 — Rivus Pharmaceuticals, Inc., a clinical-stage biopharmaceutical company pioneering...
Advertisement
